The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

NCT06050109 · clinicaltrials.gov ↗

RECRUITING

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Female
Endocrine Therapy

Interventions

DRUG: OFS continues to use group after 5 years use
DIAGNOSTIC_TEST: Immunohistochemical detection of HR status

Sponsor

Hongmei Zheng, PhD